83 results
Page 4 of 5
10-Q
em1e hovtojq
8 Nov 22
Quarterly report
4:09pm
10-Q
EX-31.1
ksgbi89qcv1r
8 Nov 22
Quarterly report
4:09pm
10-Q
EX-31.2
dmyb jfqs
8 Nov 22
Quarterly report
4:09pm
8-K
EX-1.1
y303xtn t3h9gc
21 Oct 22
Entry into a Material Definitive Agreement
4:19pm
424B5
o4f1igb1vrb55uy
21 Oct 22
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.2
3rm57d1cpepx
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:26am
8-K
EX-99.1
bdittl2t5ejci02o
19 Oct 22
Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody
6:26am
424B5
2zxukpx9nojwh
13 Oct 22
Prospectus supplement for primary offering
4:56pm
8-K12B
EX-4.2
67xf q8ip9
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-14.1
wak3ic9qft7uy
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-99.3
hwvuktu79q t56c642
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-3.4
92jddq6
13 Oct 22
Notification of registration of securities
7:24am
8-K12B
EX-99.2
7tedniwiaxt
13 Oct 22
Notification of registration of securities
7:24am
424B3
3eln6mtftkns 7wo6ohu
2 Sep 22
Prospectus supplement
4:06pm
S-4/A
EX-4.7
vjyn0a7bkpuq
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm
S-4/A
qon dhfetj62xvqceph8
19 Aug 22
Registration of securities issued in business combination transactions (amended)
4:47pm
425
xr6iw8e 5d
15 Jul 22
Business combination disclosure
5:26pm
425
2x73mnrw 8ncy2l73ekk
15 Jul 22
Business combination disclosure
5:23pm
425
cdix234sne12g3mfb1
15 Jul 22
Business combination disclosure
5:21pm
425
8r1d7ur 96igx6fq59
15 Jul 22
Business combination disclosure
5:19pm